Biological therapy for colon cancer

Biological cell immunotherapy is the best choice for treating colon cancer without chemotherapy. With the improvement of people's living standards and changes in dietary structure, the incidence of colon cancer is showing an increasing trend year by year. Colon cancer is a common digestive tract malignancy occurring in the colon, ranking third among gastrointestinal tumors. The male-female ratio is 2~3:1. The highest incidence is in the 40-50 age group.

Biological cell immunotherapy can eliminate cancer cells that cannot be eliminated by chemotherapy drugs or that remain after surgery, thereby achieving the goal of more thorough elimination of cancer cells.

Surgery is a conventional treatment for colon cancer patients. Surgery can remove tumor cells and have an immediate effect. However, incomplete surgical treatment can easily cause tumor recurrence and metastasis, which not only makes patients suffer more pain, but also brings greater life risks to patients, making patients lose the best time for treatment. Doctors from the Department of Biology of Modern Hospital said that combined biological cell immunotherapy after colon cancer surgery can solve the treatment problems of incomplete surgical treatment of colon cancer, easy recurrence and metastasis, so that colon cancer patients can have no worries.

In addition, high-dose radiotherapy and chemotherapy for advanced patients, or chemotherapy again for patients who have developed drug resistance, can only make the weak life more critical and accelerate the death of the patient. Doctors point out that combined biological cell immunotherapy can reduce the side effects of radiotherapy and chemotherapy, enhance the patient's immunity, and thus improve the effect of radiotherapy and chemotherapy.

It can be seen that the combined application of biological cell immunotherapy with modern surgery, chemotherapy and radiotherapy methods has a strong complementary effect. It not only has the effect of clearing tiny residual lesions in different parts of the body and preventing tumor recurrence and metastasis, but also has a unique role in restoring and rebuilding the patient's damaged immune system.

More importantly, biological cell immunotherapy can greatly improve the survival rate of patients. At present, biological cell immunotherapy is welcomed by the majority of cancer patients due to its advantages of non-invasiveness, no toxic side effects, and good effects. It is considered to be the most active and promising treatment method among all tumor treatment modes. Compared with other treatments, biological cell immunotherapy is cheaper and more effective, and it is a new hope for many cancer patients.

Biological cell immunotherapy is a type of tumor biological treatment and a relatively mature technology in the field of tumor biological treatment. Biological cell immunotherapy is a treatment process that extracts mononuclear cells from the patient's own peripheral blood, induces, activates and expands them into DC/CIK cells in a GMP ultra-clean laboratory, and then returns them to the patient. The main applications are DC cells and CIK cells, which have specific recognition effects on tumor cells and can widely recognize various tumor cells without distinguishing between different types of diseases. When DC and CIK cells are used in combination to completely kill malignant tumor cells or reduce and stabilize them at a certain level, clinical cure or tumor control can be achieved.

Since biological cell immunotherapy was applied in clinical practice, it has received unanimous praise from patients.

Biological cell immunotherapy has attracted many cancer patients from all over the country to seek treatment. Judging from the results of nearly 3,000 patients treated clinically, its actual efficacy has exceeded the expectations of researchers. Authoritative doctors pointed out that this biological cell immunotherapy has opened up a new treatment model besides traditional surgery, radiotherapy and chemotherapy, opened up a new way for cancer treatment in my country, and showed a bright future.